With the launch of the National Cancer Institute’s Precision Medicine Initiative in 2015, there has been a shift to trial designs that tailor health care solutions to individual patients by using a ...
SANTA ROSA, Calif.--(BUSINESS WIRE)--$KEYS #1024QAM--Keysight Technologies, Inc. (NYSE: KEYS) gained validations for the industry’s first 5G NR FR1 1024-QAM ...
SANTA ROSA, Calif.--(BUSINESS WIRE)--Keysight Technologies, Inc. (NYSE: KEYS a leading technology company that delivers advanced design and validation solutions to help accelerate innovation to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback